Gilteritinib Combined with Azacitidine as Salvage Therapy for B/Myeloid Mixed Phenotype Acute Leukemia

Mixed phenotype acute leukemia (MPAL) is a rare group of acute leukemias with blasts that co-express antigens of more than one lineage or separate populations of blasts of different lineages. Though treatment guidelines are not well established, the standard of care in treating MPAL remains the acut...

Descripción completa

Detalles Bibliográficos
Autores principales: Horvat, Nathan P, Logothetis, Constantine N, Zhang, Ling, Yun, Seongseok, Sweet, Kendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053382/
https://www.ncbi.nlm.nih.gov/pubmed/35505715
http://dx.doi.org/10.7759/cureus.23618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053382/
https://www.ncbi.nlm.nih.gov/pubmed/35505715
http://dx.doi.org/10.7759/cureus.23618

Ejemplares similares